[HTML][HTML] Evolution of patient-reported outcomes and their role in multiple sclerosis clinical trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - Elsevier
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

[HTML][HTML] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - neurotherapeuticsjournal.org
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

[PDF][PDF] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - academia.edu
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

[HTML][HTML] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - Springer
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - search.proquest.com
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - … : the journal of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - scholars.northwestern.edu
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials.

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics: the Journal of …, 2017 - europepmc.org
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

[HTML][HTML] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - ncbi.nlm.nih.gov
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …

[PDF][PDF] Evolution of Patient-Reported Outcomes and Their Role in Multiple Sclerosis Clinical Trials

CJ Nowinski, DM Miller, D Cella - Neurotherapeutics, 2017 - academia.edu
Patient-reported outcomes (PROs) are playing an increasing role in multiple sclerosis (MS)
research and practice, and are essential for understanding the effects that MS and MS …